<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="22/03/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8112299">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8112299</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T1" lex="calcineurin">Calcineurin</term> acts in synergy with <term sem="Organic_compound_other" id="T2" lex="PMA">PMA</term> to inactivate <term sem="Protein_molecule" id="T3" lex="I_kappa_B/MAD3">I kappa B/MAD3</term>, an inhibitor of <term sem="Protein_complex" id="T4" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="T3" />
<cause idref="T1" />
<cause idref="T2" />
<clue>Calcineurin acts <linkCause>in synergy with</linkCause> PMA to <clueType>inactivate</clueType> I kappa B/MAD3, an inhibitor of NF-kappa B.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="T3" />
<cause idref="T4" />
<clue>Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term sem="DNA_domain_or_region" id="T5" lex="interleukin-2_(IL-2)_promoter"><term sem="Protein_molecule" id="T6" lex="interleukin-2">interleukin-2</term> (<term sem="Protein_molecule" id="T7" lex="IL-2">IL-2</term>) promoter</term> consists of several independent <term sem="DNA_family_or_group" id="T8" lex="T_cell_receptor_(TcR)_responsive_element"><term sem="Protein_family_or_group" id="T9" lex="T_cell_receptor">T cell receptor</term> (<term sem="Protein_family_or_group" id="T10" lex="TcR">TcR</term>) responsive elements</term>.</sentence>
<sentence id="S3">The induction of <term sem="DNA_domain_or_region" id="T11" lex="promoter">promoters</term> dependent on these elements is inhibitable by the <term sem="Organic_compound_other" id="T12" lex="immunosuppressant">immunosuppressants</term> <term sem="Organic_compound_other" id="T13" lex="cyclosporin_A">cyclosporin A</term> (<term sem="Organic_compound_other" id="T14" lex="CsA">CsA</term>) and <term sem="Organic_compound_other" id="T15" lex="tacrolimus">tacrolimus</term> (<term sem="Organic_compound_other" id="T16" lex="FK-506">FK-506</term>).</sentence>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="T5" />
<cause idref="T8" />
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>promoters</corefTheme> <linkCause>dependent on</linkCause> <corefCause>these elements</corefCause> is inhibitable by the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T14" />
<clue>The induction of promoters dependent on these elements is <clueType>inhibitable</clueType> <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T16" />
<clue>The induction of promoters dependent on these elements is <clueType>inhibitable</clueType> <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<sentence id="S4"><term sem="Protein_molecule" id="T17" lex="calcineurin">Calcineurin</term>, a <term sem="Protein_molecule" id="T18" lex="Ca2+/calmodulin-dependent_protein_phosphatase"><term sem="Element" id="T19" lex="Ca2+">Ca2+</term>/calmodulin-dependent protein phosphatase</term>, is the <term sem="Organic_compound_other" id="T20" lex="FK-506">FK-506</term>- and <term sem="Organic_compound_other" id="T21" lex="CsA">CsA</term>-sensitive enzyme required for <term sem="Protein_family_or_group" id="A1">TcR</term> mediated activation of the <term sem="DNA_domain_or_region" id="T22" lex="IL-2_promoter">IL-2 promoter</term>.</sentence>
<event id="E5">
<type />
<theme idref="T17" />
<cause idref="T20" />
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-<clueType>sensitive</clueType> enzyme required for TcR mediated activation of the IL-2 promoter.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E6">
<type />
<theme idref="T17" />
<cause idref="T21" />
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-<clueType>sensitive</clueType> enzyme required for TcR mediated activation of the IL-2 promoter.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T22" />
<cause idref="A1" />
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-sensitive enzyme required for TcR <linkCause>mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the IL-2 promoter.</clue>
</event>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T17" />
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-sensitive enzyme <clueType>required</clueType> <linkTheme>for</linkTheme> TcR mediated activation of the IL-2 promoter.</clue>
</event>
<sentence id="S5">We report that a constitutively active form of <term sem="Protein_molecule" id="T23" lex="calcineurin">calcineurin</term> partially substitutes for the <term sem="Other" id="T24" lex="Ca2+_co-stimulus"><term sem="Element" id="T25" lex="Ca2+">Ca2+</term> co-stimulus</term> required to activate the <term sem="DNA_domain_or_region" id="T26" lex="IL-2_promoter_element"><term sem="DNA_domain_or_region" id="T27" lex="IL-2_promoter">IL-2 promoter</term> elements</term> <term sem="DNA_domain_or_region" id="T28" lex="IL-2A">IL-2A</term> (which binds the factors <term sem="Protein_molecule" id="T29" lex="OAP">OAP</term> and <term sem="Protein_molecule" id="T30" lex="Oct-1">Oct-1</term>) and <term sem="DNA_domain_or_region" id="T31" lex="IL-2E">IL-2E</term> (which binds <term sem="Protein_family_or_group" id="T32" lex="NF-AT">NF-AT</term>), and completely substitutes for the <term sem="Other" id="T33" lex="Ca2+_co-stimulus"><term sem="Element" id="T34" lex="Ca2+">Ca2+</term> co-stimulus</term> required to stimulate an <term sem="DNA_domain_or_region" id="A2"><term sem="Protein_complex" id="T35" lex="NF-kappa_B">NF-kappa B</term>-dependent element</term>.</sentence>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T28" />
<cause idref="T24" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T31" />
<cause idref="T24" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E50">
<type class="Positive_regulation" />
<theme idref="T28" />
<cause idref="T23" />
<clue>We report that a constitutively active form of calcineurin <clueType>partially</clueType> substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E51">
<type class="Positive_regulation" />
<theme idref="T31" />
<cause idref="T23" />
<clue>We report that a constitutively active form of calcineurin <clueType>partially</clueType> substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="T33" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to <clueType>stimulate</clueType> an NF-kappa B-dependent element.</clue>
</event>
<event id="E52">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="T23" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to <clueType>stimulate</clueType> an NF-kappa B-dependent element.</clue>
</event>
<event id="E23">
<type class="Binding" />
<theme idref="T28" />
<theme idref="T29" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which <clueType>binds</clueType> the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="T28" />
<theme idref="T30" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which <clueType>binds</clueType> the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event id="E25">
<type class="Binding" />
<theme idref="T31" />
<theme idref="T32" />
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which <clueType>binds</clueType> NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<sentence id="S6"><term sem="Protein_molecule" id="T36" lex="calcineurin">Calcineurin</term> stimulates the <term sem="DNA_domain_or_region" id="T37" lex="NF-kappa_B_element"><term sem="Protein_complex" id="T38" lex="NF-kappa_B">NF-kappa B</term> element</term> by enhancing inactivation of <term sem="Protein_molecule" id="T39" lex="I_kappa_B/MAD3">I kappa B/MAD3</term>, an inhibitor of <term sem="Protein_complex" id="T40" lex="NF-kappa_B">NF-kappa B</term>, thereby increasing the amount of nuclear <term sem="Other" id="T41" lex="NF-kappa_B_DNA_binding_activity"><term sem="Protein_complex" id="T42" lex="NF-kappa_B">NF-kappa B</term> <term sem="DNA_molecule" id="A5">DNA</term> binding activity</term>.</sentence>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="T39" />
<clue>Calcineurin stimulates the NF-kappa B element by enhancing <clueType>inactivation</clueType> <linkTheme>of</linkTheme> I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="E13" />
<cause idref="T36" />
<clue>Calcineurin stimulates the NF-kappa B element by <clueType>enhancing</clueType> inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T37" />
<cause idref="E14" />
<clue>Calcineurin <clueType>stimulates</clueType> the NF-kappa B element <linkCause>by</linkCause> enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E26">
<type class="Binding" />
<theme idref="T42" />
<theme idref="A5" />
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of <clueLoc>nuclear</clueLoc> NF-kappa B DNA <clueType>binding</clueType> activity.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="E26" />
<cause idref="E15" />
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, <linkCause>thereby</linkCause> <clueType>increasing</clueType> the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E53">
<type class="Negative_regulation" />
<theme idref="T40" />
<cause idref="T39" />
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<sentence id="S7">These data provide the first demonstration <term sem="Other" id="T43" lex="in_vivo">in vivo</term> that activation of a <term sem="Protein_family_or_group" id="T44" lex="protein_phosphatase">protein phosphatase</term> can inactivate <term sem="Protein_molecule" id="T45" lex="I_kappa_B">I kappa B</term>, and suggest one possible explanation for <term sem="Other" id="T46" lex="mechanism-based_toxicity">mechanism-based toxicities</term> associated with <term sem="Organic_compound_other" id="T47" lex="FK-506">FK-506</term> and <term sem="Organic_compound_other" id="T48" lex="CsA">CsA</term> by demonstrating that these drugs can inhibit the <term sem="Other" id="T49" lex="calcineurin-dependent_activation"><term sem="Protein_molecule" id="T50" lex="calcineurin">calcineurin</term>-dependent activation</term> of a virtually <term sem="Protein_family_or_group" id="T51" lex="ubiquitous_transcription_factor">ubiquitous transcription factor</term>.</sentence>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T44" />
<clue>These data provide the first demonstration in vivo that <clueType>activation</clueType> <linkTheme>of</linkTheme> a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="T45" />
<cause idref="E17" />
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can <clueType>inactivate</clueType> I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="T51" />
<cause idref="T50" />
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-<linkCause>dependent</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> a virtually ubiquitous transcription factor.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T47" />
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that <corefCause>these drugs</corefCause> can <clueType>inhibit</clueType> the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T48" />
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that <corefCause>these drugs</corefCause> can <clueType>inhibit</clueType> the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
